StockData

Cartesian Therapeutics, Inc. (RNAC) bonds

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)

Close on Nov 16, 2026Market cap $183.95MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$52.85M
Long-term debt
Net debt
-$94.76M
After $147.61M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Cartesian Therapeutics's 10-Q for the period ended Jun 30, 2026

Cartesian Therapeutics's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Loan Agreement$150.00M$53.48M

See a number that looks wrong?